RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

Sep 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-09-10

Reporting Person: Mayer Eldon C. III (EVP & Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-10	Common Stock	P	50000	$3.2842	Acquired	165000	Direct
2018-09-11	Common Stock	P	50000	$3.2268	Acquired	215000	Direct

Footnotes

F1: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transaction ranging from $3.26 to $3.31. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each separate price.

F2: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transaction ranging from $3.19 to $3.27. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each separate price.